Advancing the Cardiovascular Care of the Oncology Patient
COURSE OVERVIEW/STATEMENT OF NEED
Cardiovascular disease is the second leading cause of morbidity and mortality in cancer survivors. Since an estimated 14.5 million cancer patients and survivors have significant cardiovascular risk factors, it is critical for cardiologists, oncologists, and the entire multi-professional care team to stay on the leading edge of this rapidly evolving field. Advancing the Cardiovascular Care of the Oncology Patient provides clinicians and researchers with the tools needed to improve patient care in your everyday practice.
Over the past 3 years, the American College of Cardiology has joined forces with respected experts in the field of Cardio-oncology to develop a program covering the most relevant and required content for both the novice and advancing practitioner. Join us at Advancing the Cardiovascular Care of the Oncology Patient and engage with our growing community. Participate through interactive case discussions on evidence-based treatment strategies that address pre, intra and post-chemotherapy heart health. Throughout the course, you'll have the unique opportunity to engage with expert faculty and a network of colleagues centered around ensuring your patients receive the most informed care possible.
The overall goal of this course is to provide clinically relevant, state-of-the-art, best practice strategies for the interprofessional team in the assessment, diagnosis and management of cardiovascular concerns for patients with cancer and/or those requiring survivorship care.
This course is intended for cardiologists, oncologists, internists and all members of the multi-professional care team (including advanced practice nurses, physician assistants, pharmacists, exercise physiologists) who are providing clinical care to the growing population of cancer patients and survivors with cardiovascular concerns.
- Identify common cancer treatment therapies such as anthracyclines, Herceptin, VEGF inhibitors and immunotherapies role in cancer treatment, mechanism of action including cardiotoxicity and resulting cardiovascular disease impact.
- Recognize appropriate imaging modalities to assess cardiotoxicity, and distinguish the strengths and weaknesses of each cardiac monitoring modality, including echocardiography, strain, CT, MRI, and nuclear imaging
- Evaluate guidelines from the cardiology and oncology societies and how to incorporate into clinical practice
- Evaluate best practices for monitoring patients receiving cardiotoxic cancer therapies and know how to integrate findings into cardiovascular care plans
- Analyze the long-term surveillance and management plan critical for patients who have received high risk systemic therapies such as anthracyclines and those treated with thoracic radiation
- Identify best practices when developing and building the interprofessional cardio-oncology team and organizational frameworks needed for success
Ana Barac, MD, PhD, FACC
MedStar Washington Hospital Center
Bonnie Ky, MD, MSCE, FACC
Perelman School of Medicine
University of Pennsylvania
Christopher M. Domenico, PharmD
University of Pennsylvania
Anecita Fadol, PhD, RN, FNP, FAANP
The University of Texas MD Anderson Cancer Center
CONFLICT OF INTEREST (COI) POLICY/DISCLOSURES
ACCF committee members, faculty, staff and other individuals who are in a position to control the content of this activity are required to disclose all relevant financial relationships he/she and/or his/her spouse or domestic partner has, occurring within the past twelve months, with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. All relevant potential conflicts of interest that are identified are thoroughly vetted by course directors, ACCF education staff, and members of the Accreditation Compliance Workgroup through a process that includes appropriate peer review for fair balance, scientific objectivity and validity, and patient care and safety recommendations. Refer to the links below for committee member disclosures and course faculty disclosures. Please note ACCF staff involved with this course have nothing to disclose.
to view the Advancing the Cardiovascular Care of the Oncology Patient Agenda.
2019 Pre-conference Educational Seminar: Common Cancer Pharmacotherapies and the CV Patient
In direct response to your feedback, we will kick off Friday evening with an optional, limited-seating pre-conference titled Common Cancer Pharmacotherapies and the CV Patient. The 3-hour intensive session is devoted to common conventional and newer highly targeted cancer therapies. The focus of the course will include Anthracyclines, HER2-Targeted Therapies, VEGF-Targeted Therapies and Immunotherapies.
Friday, January 25, 2019
4:00 p.m. – 7:00 p.m. at Heart House
Pre-conference Registration Rate = $100
25% Discount to Pre-conference if included with course registration – ends Sept 7, 2018
Limited Seating 110 people – Register Early and SAVE
To Register online for the Course please click the Register button at the top of the page.
If you have any special Dietary requirements, please note that this is now captured through your online profile. To enable us to accommodate your request, please ensure that your profile is up to date. If you select the (other) option, a member of our team will be in touch to discuss your needs. If you require assistance, please contact the Resource Center at 800-253-4636, ext. 5603.
To Register by Fax or Ground Mail for the Course click here.
|Please register me as:||Designation|| Early Before 10/19/18
|Member Physician (includes International Associate)
||MD, DO, PhD||$550
||MD, DO, PhD||$775
(Includes CCA Members, CVT, FIT, Resident, Student and Emeritus)
||PA, RN, NP, CNS, PharmD,
FIT, Emeritus, Resident, Student
||PA, RN, NP, CNS, PharmD
The registration tuition includes educational sessions, continental breakfasts, refreshment breaks, lunch and course materials.
Cancellation, substitution or transfer to another course is allowed if written notification is received four weeks before a scheduled course. A full refund minus a $250 processing fee will be given for written notifications received fewer than four weeks before the first day of the course. No refund will be given for no-shows.
ACC reserves the right to cancel the course in the unlikely event of insufficient enrollment or other unforeseen circumstances. If a course is canceled or postponed, ACC will refund registration tuition but cannot be held responsible for other costs or expenses, including cancellation/change penalties assessed by airlines, travel agencies or hotels.
Thank you for your interest in submitting an abstract for Advancing the Cardiovascular Care of the Oncology Patient scheduled for January 25-27, 2019 in Washington, DC.
Submission Site: The abstract submission site is now open at https://podio.com/webforms/21792822/1520578
Submission Deadline has been extended! All abstracts must be submitted by 11:59 p.m. EST on December 10, 2018.
Please ensure you have read the abstract policies and procedures and submission instructions thoroughly before submitting your abstract.
The American College of Cardiology Foundation (ACCF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The ACCF designates this live activity for a maximum of 16.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 16.25 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
The American College of Cardiology Foundation is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation (ANCC Provider number 0019).
ACCF designates this educational activity for a maximum of 16.25 continuing nursing education contact hours (10.25 CNE pharmacotherapeutic contact hours). Nurses should claim only the credit commensurate with the extent of their participation in the activity.
This activity is eligible for ACPE credit, see final CPE activity announcement for specific details.
LEARNER BILL OF RIGHTS
All sessions will be held at The Ritz-Carlton, Washington DC, 1150 22nd Street, NW, Washington, DC. The meeting site telephone number is 202-835-0500.
The Ritz-Carlton, Washington DC 1150 22nd Street, NW Washington, DC 20037
Online Reservation Link:
Click here to make your reservations online
Reservations via telephone:
To make a reservation by phone, you can either call the hotel direct at 202-835-0500 or 800--558-9994 and identify yourself as being with the American College of Cardiology/Advancing the Cardiovascular Care of the Oncology Patient group.
The ACC negotiated room rate is $239 per night plus state and local taxes (currently 14.5%) per night. The ACC room block is scheduled to be held until January 7, 2019, but may sell out prior to this date. We advise you to register for the course and reserve your lodging as soon as possible.
Smoking is prohibited in all ACC meeting rooms.
We encourage participation by all individuals. If you have a disability, advance notification of any special needs will help us serve you better.
Faculty and course are subject to change without notice.
Accredited status does not imply endorsement by the ANCC or ACC of any commercial products displayed in conjunction with this activity.
The views expressed in this course are those of the individual speaker and do not necessarily reflect the views of the ACC.
Pleaseto review the Exhibitor Prospectus for additional information regarding exhibiting at Advancing the Cardiovascular Care of the Oncology Patient.
Clinical Topics: Cardio-Oncology
Keywords: Cardiotoxins, Cardiotoxicity, Medical Oncology, Immunotherapy, Thrombosis, Chronic Disease, Life Style, Anthracyclines